Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.61%
SPX
+0.54%
IXIC
+0.65%
FTSE
+0.27%
N225
+0.17%
AXJO
-0.04%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
Health Care
avtx
Avalo Therapeutics
NASDAQ: AVTX
+0.52 (+2.80%)
19.07
USD
At close at Nov 28, 21:40 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Cashu News

publisher logo
Cashu

Overview of Avalo Therapeutics: Key Developments and Market Insights

about 2 months ago
publisher logo
Cashu

Avalo Therapeutics: Key Updates and Developments in Recent Performance and Strategy.

2 months ago
publisher logo
Cashu

Summary Request for Avalo Therapeutics: Please Provide Content for Analysis

2 months ago

Latest Avalo Therapeutics News

benzinga.com

12 Health Care Stocks Moving In Monday's Pre-Market Session

2 months ago
finance.yahoo.com

KaliVir Immunotherapeutics Appoints Schond Greenway as Chief Financial Officer

Feature Image for interests on Avalo Therapeutics, Biotech Company, Clinical Development, Corporate Finance from finance.yahoo.com
about 1 year ago
businesswire.com

KaliVir Immunotherapeutics Appoints Schond Greenway as Chief Financial Officer

Feature Image for interests on ETF, Financial Services, Healthcare, Stock from businesswire.com
about 1 year ago
finance.yahoo.com

Avalo Announces Participation in September Investor Conferences

Feature Image for interests on Avalo Therapeutics, Avtx, Chief Executive Officer, Fireside Chat from finance.yahoo.com
about 1 year ago
finance.yahoo.com

Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates

Feature Image for interests on Avalo, Avalo Therapeutics, Cash And Cash Equivalents, Financial Statements from finance.yahoo.com
over 1 year ago
benzinga.com

Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer

over 1 year ago
benzinga.com

Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer

over 1 year ago
benzinga.com

Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit

over 1 year ago
finance.yahoo.com

Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates

Feature Image for interests on Avalo, Avalo Therapeutics, Gross Proceeds, Healthcare from finance.yahoo.com
over 1 year ago
benzinga.com

Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades

Feature Image for interests on Abbv, Analyst Color, Analyst Ratings, Avtx from benzinga.com
over 1 year ago
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.